Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Lantern Pharma Announces Initial Patients Dosed in First-In-Human Clinical Trial for AI-Guided Drug-Candidate, LP-284
Saturday, March 16, 2024Lantern Pharma Inc an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary AI and machine learning platform RADR with multiple clinical stage drug
Madrigal Pharmaceuticals FDA Approves Rezdiffra™ for NASH with Liver Fibrosis
Friday, March 15, 2024Madrigal Pharmaceuticals Inc a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis today announced that the US Food and Drug Administration
Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors
Friday, March 15, 2024Nuvation Bio Inc a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates today announced that the first patient has been dosed
Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma
Thursday, March 14, 2024Poseida Therapeutics Inc a clinicalstage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases
Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder
Thursday, March 14, 2024Cybin Inc a clinical stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
Thursday, March 14, 2024Pfizer Inc today announced that the European Commission has granted marketing authorization for the companys valent pneumococcal conjugate vaccine
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
Wednesday, March 13, 2024Allogene Therapeutics Inc a clinicalstage biotechnology company pioneering the
Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
Wednesday, March 13, 2024Greenwich LifeSciences Inc a clinicalstage biopharmaceutical company focused on its Phase III clinical trial FLAMINGO which is evaluating GLSI an immunotherapy to prevent breast cancer recurrences
Poltreg Receives CGMP Certification to Produce Cell Therapies at Its State-of-the-art Manufacturing Site in Poland
Tuesday, March 12, 2024Poltreg SA a clinicalstage biotechnology company developing cellular therapies for a range of autoimmune diseases today announces it has received CGMP certification from Polands Chief Pharmaceutical Inspectorate
Bluebird Bio Announces First Outcomes-based Agreement With Medicaid for Sickle Cell Disease Gene Therapy
Tuesday, March 12, 2024Bluebird bio Inc today announced it has signed its first Medicaid outcomesbased agreement for LYFGENIA with the state of Michigan LYFGENIA is a onetime gene therapy approved for the treatment of patients years of age
